
Revolutionizing Cornea Repair
Our engineered cornea is a true alternative to donor cornea while also offering corrective vision to the almost 13 million people globally on a donor cornea tissue waiting list.
The Problem
Corneal blindness is not rare—but donor cornea is
2 million
suffer from corneal blindness each year
One in 70
patients who need cornea tissue obtain it
13 million
globally are on a donor cornea tissue waiting list
Our Solution
CorneaClear™
The gift of sight for those who once could see
The Benefits of CorneaClear™
About Us
Our Vision
To expand patient access to solutions that restore, repair or rebuild damaged cornea tissue
We are developing partnerships with potential technology licensees and multiple contract organizations to market the engineered cornea.
Our Team
Visionaries in Ophthalmic Technology
We bring together bioengineering and technology to revolutionize corneal transplants
Our Partners
Invest with purpose at BioLattice




By supporting our cutting-edge research in tissue engineering, you’re not just investing in a company; you’re investing in the future of healthcare. Your commitment fuels breakthroughs that have the power to redefine medical possibilities and positively impact countless lives.
Please send us a quick message if you would like an investor presentation. We will contact you to schedule a convenient time
Press
The latest from BioLattice
Technically
May 16, 2025
HiveBio
Apr 24, 2025
Technically
Nov 1, 2023
Dec, 2023
Philadelphia Magazine
Mar 18, 2021
OptImpact